Published in Am J Med on November 08, 1999
Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology (1995) 3.95
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med (2000) 3.71
The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology (2000) 3.25
A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med (2001) 3.05
Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut (1997) 2.77
Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences. Ann Intern Med (1997) 2.60
Cyclic vomiting syndrome in adults. Neurogastroenterol Motil (2008) 2.40
Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology (1994) 2.39
Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology (1997) 2.39
Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther (2013) 2.26
Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol Gastrointest Liver Physiol (2002) 2.10
Stimulus and site specific induction of hiccups in the oesophagus of normal subjects. Gut (1997) 2.10
Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil (2007) 1.98
Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain (2000) 1.97
Sleep disturbances in clinic patients with functional bowel disorders. Am J Gastroenterol (2000) 1.96
Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology (1997) 1.94
The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther (2004) 1.76
Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology (1998) 1.70
Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther (1999) 1.66
Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med (2001) 1.64
Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain. Neurogastroenterol Motil (2009) 1.58
Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol (2001) 1.57
Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. Arch Intern Med (2001) 1.55
Estradiol inhibits atp-induced intracellular calcium concentration increase in dorsal root ganglia neurons. Neuroscience (2003) 1.53
Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol (1999) 1.49
Symptoms and visceral perception in severe functional and organic dyspepsia. Gut (1998) 1.48
Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention. Aliment Pharmacol Ther (2012) 1.47
Gender-related differences in IBS symptoms. Am J Gastroenterol (2001) 1.47
Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment Pharmacol Ther (1997) 1.45
Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis. Neuroimage (2008) 1.43
CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats. Gut (2005) 1.41
Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil (2008) 1.41
Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. Am J Gastroenterol (2001) 1.40
Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients. Am J Gastroenterol (2000) 1.38
Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol (1998) 1.37
Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut (2005) 1.37
Rectal afferent function in patients with inflammatory and functional intestinal disorders. Pain (1996) 1.35
An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol (2003) 1.34
Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil (2009) 1.32
Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology (2001) 1.28
Effects of the corticotropin-releasing factor (CRF) on rectal afferent nerves in humans. Neurogastroenterol Motil (1996) 1.24
Gender differences in regional brain response to visceral pressure in IBS patients. Eur J Pain (2000) 1.23
Neurokinin 1 receptor internalization in spinal cord slices induced by dorsal root stimulation is mediated by NMDA receptors. J Neurosci (1997) 1.21
Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol (1999) 1.19
Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br J Pharmacol (2001) 1.18
Audio and visual stimulation reduces patient discomfort during screening flexible sigmoidoscopy. Am J Gastroenterol (1998) 1.17
Long-term evaluation of pylorus preservation during pancreaticoduodenectomy. World J Surg (1988) 1.17
Perceptual responses in patients with inflammatory and functional bowel disease. Gut (2000) 1.13
Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Aliment Pharmacol Ther (2001) 1.13
Symptoms and physiology in severe chronic constipation. Am J Gastroenterol (1999) 1.11
Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther (1997) 1.10
Differential effects of chemical and mechanical colonic irritation on behavioral pain response to intraperitoneal acetic acid in mice. Pain (1999) 1.09
Subtypes of constipation predominant irritable bowel syndrome based on rectal perception. Gut (1998) 1.08
Gastric processing and emptying of fat. Gastroenterology (1986) 1.04
The effect of octreotide on human gastric compliance and sensory perception. Neurogastroenterol Motil (1995) 1.00
Sleep and duodenal motor activity in patients with severe non-ulcer dyspepsia. Gut (1994) 0.98
Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis. Ophthalmology (1993) 0.98
Substance P release in the dorsal horn assessed by receptor internalization: NMDA receptors counteract a tonic inhibition by GABA(B) receptors. Eur J Neurosci (1999) 0.98
Sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia. Digestion (1998) 0.97
Internalization of mu-opioid receptors in rat spinal cord slices. Neuroreport (1999) 0.95
Involvement of spinal calcitonin gene-related peptide in the development of acute visceral hyperalgesia in the rat. Neurogastroenterol Motil (2001) 0.94
Irritable bowel syndrome patients show altered sensitivity to exogenous opioids. Pain (2000) 0.94
Calcium waves in colonic myocytes produced by mechanical and receptor-mediated stimulation. Am J Physiol (1999) 0.93
Autonomic response to a visceral stressor is dysregulated in irritable bowel syndrome and correlates with duration of disease. Neurogastroenterol Motil (2013) 0.93
Acute tryptophan depletion alters the effective connectivity of emotional arousal circuitry during visceral stimuli in healthy women. Gut (2011) 0.93
Sensational developments in the irritable bowel. Gut (1996) 0.92
Gastroenterologic causes of chronic pelvic pain. Obstet Gynecol Clin North Am (1993) 0.92
Propagation of calcium waves between colonic smooth muscle cells in culture. Cell Calcium (1996) 0.91
Consensus statement on depression, anxiety, and functional gastrointestinal disorders. J Clin Psychiatry (2001) 0.91
Sigmoid afferent mechanisms in patients with irritable bowel syndrome. Dig Dis Sci (1997) 0.91
Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study. Aliment Pharmacol Ther (2008) 0.91
Sex-dependent differences in the activity and modulation of N-methyl-d-aspartic acid receptors in rat dorsal root ganglia neurons. Neuroscience (2007) 0.90
Anti-hyperalgesic effect of octreotide in patients with irritable bowel syndrome. Aliment Pharmacol Ther (2004) 0.89
Traditional Chinese medicine based subgrouping of irritable bowel syndrome patients. Am J Chin Med (2005) 0.88
Subdiaphragmatic vagal afferent innervation in activation of an opioidergic antinociceptive system in response to colorectal distension in rats. Neurogastroenterol Motil (2002) 0.88
Mechanical activation of dorsal root ganglion cells in vitro: comparison with capsaicin and modulation by kappa-opioids. Brain Res (2000) 0.88
Selective knockdown of NMDA receptors in primary afferent neurons decreases pain during phase 2 of the formalin test. Neuroscience (2010) 0.88
Duodenal fat intensifies the perception of heartburn. Gut (2001) 0.87
Gastric emptying and sieving of solid food and pancreatic and biliary secretion after solid meals in patients with truncal vagotomy and antrectomy. Gastroenterology (1982) 0.87
N-methyl-D-aspartate receptors enhance mechanical responses and voltage-dependent Ca2+ channels in rat dorsal root ganglia neurons through protein kinase C. Neuroscience (2004) 0.86
Sex-related differences in prepulse inhibition of startle in irritable bowel syndrome (IBS). Biol Psychol (2010) 0.86
Temporal relationships of cholecystokinin release, pancreatobiliary secretion, and gastric emptying of a mixed meal. Gastroenterology (1988) 0.85
Familial visceral neuropathy with autosomal dominant transmission. Gastroenterology (1986) 0.85
Impact of advertisement and clinic populations in symptoms and perception of irritable bowel syndrome. Aliment Pharmacol Ther (1999) 0.84
Involvement of substance P in noncholinergic excitation of rabbit colonic muscle. Am J Physiol (1989) 0.84
Reassessment of gastric acid inhibition by cholecystokinin and gastric inhibitory polypeptide in dogs. Gastroenterology (1982) 0.84
Characterization of afferent mechanisms in ileoanal pouches. Am J Gastroenterol (1997) 0.83
Towards an integrative model of irritable bowel syndrome. Prog Brain Res (2000) 0.83
Toward a biobehavioral model of visceral hypersensitivity in irritable bowel syndrome. J Psychosom Res (1998) 0.83
Characterization of bombesin effects on canine gastric muscle. Am J Physiol (1982) 0.82
Symptom duration in patients with irritable bowel syndrome. Am J Gastroenterol (1996) 0.82